🇺🇸 FDA
Patent

US 10434105

Therapeutically active compounds and their methods of use

granted A61KA61K31/53A61P

Quick answer

US patent 10434105 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/53, A61P, A61P35/00, A61P35/02